USANA Health Sciences Inc (USNA)
Receivables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 923,915 | 1,001,720 | 1,190,170 | 1,137,750 | 1,060,900 |
| Receivables | US$ in thousands | 7,201 | 7,213 | 7,163 | 7,420 | 8,762 |
| Receivables turnover | 128.30 | 138.88 | 166.16 | 153.34 | 121.08 |
December 31, 2023 calculation
Receivables turnover = Revenue ÷ Receivables
= $923,915K ÷ $7,201K
= 128.30
The receivables turnover ratio measures how efficiently a company collects its outstanding receivables during a specific period. A higher receivables turnover ratio indicates that the company is collecting its outstanding accounts receivables more frequently.
Analyzing the receivables turnover ratio of USANA Health Sciences Inc over the past five years, there appears to be a fluctuating trend. In 2023, the receivables turnover ratio decreased to 128.30 from 138.88 in 2022. This indicates that the company took longer to collect its accounts receivables in 2023 compared to 2022.
However, looking at a broader trend, the receivables turnover ratio has shown variations over the past five years with fluctuating values. The highest receivables turnover was observed in 2021 at 166.16, indicating that the company efficiently collected its outstanding receivables during that period. In contrast, the lowest turnover ratio was seen in 2019 at 121.08.
Overall, the fluctuation in the receivables turnover ratio of USANA Health Sciences Inc suggests varying efficiency levels in collecting outstanding receivables over the years. Further analysis and comparison with industry benchmarks may provide additional insights into the company's accounts receivables management efficiency.